On Friday, Shares of Microsoft Corporation (NASDAQ:MSFT), lost -0.09% to $46.62.
Microsoft Corporation, will publish fiscal year 2015 fourth-quarter financial results after the close of the market on Tuesday, July 21, 2015 on the Microsoft Investor Relations website at http://www.microsoft.com/investor. A live webcast of the earnings conference call will be made accessible at 2:30 p.m. Pacific Time.
Microsoft Corporation develops, licenses, markets, and supports software, services, and devices worldwide. The company’s Devices and Consumer (D&C) Licensing segment licenses Windows operating system and related software; Microsoft Office for consumers; and Windows Phone operating system.
Shares of Boston Scientific Corporation (NYSE:BSX), declined -0.06% to $17.94, during its last trading session.
Boston Scientific Corporation, declared the election of Donna A. James to its board of directors, effective right away.
Donna A. James is the founder and managing director of Lardon & Associates LLC, a business development and executive advisory services firm. Ms. James has more than 30 years of diverse administration and leadership experience, counting serving as the former president of Nationwide Planned Investments, a division of Nationwide Mutual Insurance Company, where she had direct responsibility for developing and executing strategies for U.S. and global financial services auxiliaries and associates. Ms. James is also the founder and chair of The Center for Healthy Families, a non-profit in Columbus, Ohio, and the former president and designated chair of the National Women’s Business Council. She received her B.S. in Accounting from North Carolina A&T State University.
Ms. James presently serves as a director of Time Warner Cable Inc., L Brands, Inc., Marathon Petroleum Inc., in addition to FIS Group, a privately-held asset administration and investment advisory firm.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Administration, and MedSurg.
Finally, Lannett Company, Inc. (NYSE:LCI), ended its last trade with -2% loss, and closed at $59.85.
Lannett Company, declared that its Board of Directors has amended the corporation’s bylaws to repeal Article XII in its entirety, effective July 31, 2015. By repealing Article XII, the company has removed the provision in its bylaws which sought to shift the legal fees associated with certain types of shareholder litigation to the plaintiff-shareholder if the shareholder’s lawsuit was unsuccessful.
“The board adopted the original provision in an effort to deter frivolous shareholder claims, which can be costly to our shareholders,” said Arthur Bedrosian, chief executive officer. “Given the sentiment in the Delaware legislature, the board has repealed Article XII.”
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of branded pharmaceutical products in the United States. It offers solid oral, extended release, topical, and oral solution finished dosage forms of drugs that address a range of therapeutic areas.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.